Regencell Bioscience Limited (RGC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regencell Bioscience Lim...

    NASDAQ: RGC · Real-Time Price · USD
    17.10
    0.95 (5.88%)
    At close: Oct 03, 2025, 3:59 PM
    16.99
    -0.64%
    After-hours: Oct 03, 2025, 07:45 PM EDT

    Regencell Bioscience Balance Sheet Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Cash & Equivalents
    		 2.96M 1.56M 6.42M 59.41K
    Short-Term Investments
    		 5M 10M 10M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 97.68K 108.5K 114.3K 191.42K
    Receivables
    		 152.78K 56.55K 27.6K 7.44K
    Inventory
    		 n/a -56.55K -27.6K n/a
    Other Current Assets
    		 n/a n/a n/a -7.44K
    Total Current Assets
    		 8.11M 11.62M 16.44M 66.85K
    Property-Plant & Equipment
    		 226.51K 891.91K 1.46M 81.86K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 324.2K 1M 1.57M 273.29K
    Total Assets
    		 8.44M 12.62M 18.02M 340.13K
    Account Payables
    		 n/a n/a n/a n/a
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 410.99K 3.68M
    Other Current Liabilities
    		 n/a n/a -410.99K n/a
    Total Current Liabilities
    		 193.58K 606.91K 577.76K 4.34M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 25.93K 25.41K 360.27K n/a
    Total Liabilities
    		 219.51K 632.32K 938.03K 4.34M
    Total Debt
    		 85.74K 463.67K 771.25K 3.68M
    Book Value
    		 8.22M 11.99M 17.08M -4M
    Book Value Per Share
    		 0.02 0.02 0.03 -0.01
    Common Stock
    		 130.00 130.00 130.00 100.00
    Retained Earnings
    		 -21.62M -17.32M -11.44M -4M
    Comprehensive Income
    		 -45.77K -86.66K n/a n/a
    Shareholders Equity
    		 8.22M 12.03M 17.07M -4M
    Total Investments
    		 5M 10M 10M n/a

    Add to Watchlist